ATAI Boosts Investor Visibility With Four Major Healthcare Conferences in June 2026
ATAI plans participation in four major investor conferences in June 2026, showcasing mental health pipeline including Phase 3-bound BPL-003 for treatment-resistant depression.
ATAIinvestor conferencesclinical-stage